[1]徐馨雅,白玉,卢荣,等.肾血管平滑肌脂肪瘤瘤体成分预测经动脉栓塞术后疗效 [J].介入放射学杂志,2024,33(08):855-859.
 XU Xinya,BAI Yu,LU Rong,et al.The application of tumor components of renal angiomyolipoma in predicting the early efficacy of arterial embolization treatment[J].journal interventional radiology,2024,33(08):855-859.
点击复制

肾血管平滑肌脂肪瘤瘤体成分预测经动脉栓塞术后疗效
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
33
期数:
2024年08
页码:
855-859
栏目:
肿瘤介入
出版日期:
2024-08-12

文章信息/Info

Title:
The application of tumor components of renal angiomyolipoma in predicting the early efficacy of arterial embolization treatment
作者:
徐馨雅白玉卢荣杨灏赵超云吴龙云童媛媛陈勇
Author(s):
XU XinyaBAI YuLU RongYANG HaoZHAO ChaoyunWU LongyunTONG YuanyuanCHEN Yong.
Clinical Medical College,Ningxia Medical University,Yinchuan,Ningxia Hui Autonomous Region 750004,China
关键词:
【关键词】肾血管平滑肌脂肪瘤 CT 3D体积 阈值 成分测量
文献标志码:
A
摘要:
【摘要】目的探究肾血管平滑肌脂肪瘤(angiomyolipoma,AML)瘤体成分预测经肾动脉栓塞(selective arterial embolization,SAE)后的疗效。方法回顾性分析2019年8月至2023年4月宁夏医科大学总医院23例肾AML行SAE患者的临床资料。比较患者SAE前后肿瘤总体积、脂肪体积、非脂肪体积、脂肪体积占比、非脂肪体积占比。采用Pesrson相关分析各肿瘤成分初始体积与肿瘤体积减少率的关系,采用多元线性回归分析肿瘤体积减少率的影响因素。 结果与SAE前相比,术后肿瘤体积、脂肪体积、非脂肪体积均显著缩小(均P<0.01),术后脂肪体积占比增加,非脂肪体积占比减小(P<0.05);术后肿瘤体积缩小值与肿瘤成分体积、破裂存在相关性(P<0.05);在多因素回归分析中,非脂肪成分体积占比为肿瘤体积减小的独立危险因素。结论肾AML经SAE后非脂肪体积占比减小,术前测量该指标有助于预测术后肿瘤体积缩小率,评估患者术后疗效。

参考文献/References:

[1]Wang C,Li X,Peng L,et al.An update on recent developments in rupture of renal angiomyolipoma[J].Medicine(Baltimore),2018,97:e497.
[2]Wang B,Wen C,Song S,et al.Safety and efficacy of endovascular management of high-grade blunt renal injury[J].J Interv Med,2022,5:23-27.
[3]Zuo M,Yuan H,Ou S,et al.Superselective transcatheter arterial embolization to control renal hemorrhage after partial nephrectomy for renal tumors:a report of 9 cases and a literature review[J].J Interv Med,2019,2:134-138.
[4]Hocquelet A,Cornelis F,Le Bras Y,et al.Long-term results of preventive embolization of renal angiomyolipomas:evaluation of predictive factors of volume decrease[J].Eur Radiol,2014,24:1785-1793.
[5]陶晋.改良评分系统在肾血管平滑肌脂肪瘤保留肾单位手术中的临床价值研究[D].郑州:郑州大学,2019.
[6]Bhatt JR,Richard PO,Kim NS,et al.Natural history of renal angiomyolipoma(AML):most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy[J].Eur Urol,2016,70:85-90.
[7]Caliò A,Brunelli M,Segala D,et al.Angiomyolipoma of the kidney:from simple hamartoma to complex tumour[J].Pathology,2021,53:129-140.
[8]Planche O,Correas JM,Mader B,et al.Prophylactic embolization of renal angiomyolipomas:evaluation of therapeutic response using CT 3D volume calculation and density histograms[J].J Vasc Interv Radiol,2011,22:1388-1395.
[9]陈卫,倪才方,王煊.血管内栓塞治疗肾脏良性血管性病变[J].介入放射学杂志,2012,21:293-296.
[10]李亚华,任克伟,韩新巍.肾血管平滑肌脂肪瘤破裂出血伴肾内多发动脉瘤介入治疗1例[J].介入放射学杂志,2018,27:313-315.
[11]Lin LT,Wang CG,Pei RG,et al.Prophylactic selective arterialembolization for renal angiomyolipomas:efficacy and evaluation of predictive factors of significant shrinkage[J].Int Urol Nephrol,2018,50:1765-1770.
[12]刘德樟,周小忠,刘翠钰,等.典型肾血管平滑肌脂肪瘤自发破裂出血的MSCT研究[J].中国CT和MRI杂志,2018,16:104-106,116.
[13]王旭,宋歌,石磊,等.不同勾画感兴趣区方法鉴别肾富血供良、恶性小肿瘤[J].中国医学影像技术,2021,37:1706-1710.
[14]Gong M,Liu Z,Su H,et al.Urgent transcatheter arterial embolization for wunderlich syndrome with hypovolemic shock secondary to ruptured renal angiomyolipoma[J].Front Surg,2021,8:704478.
[15]Lin L,Li X,Guan H,et al.Renal function,complications,and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas:a meta-analysis[J].J Int Med Res,2019,47:1417-1428. 

相似文献/References:

[1]陈万海,沈晓文,孙新刚,等. 经皮肺活检常见并发症风险因素分析[J].介入放射学杂志,2012,(02):168.
 CHEN Wan-hai,SHEN Xiao-wen,SUN Xin-gang,et al.The common complications in percutaneous lung biopsy: an analysis of the relevant risk factors[J].journal interventional radiology,2012,(08):168.
[2]吴良浩,宋汉章,陈新龙,等.经皮经脾碘油门静脉造影——肝内占位性病变的平片和 CT 观察[J].介入放射学杂志,1995,(01):3.
[3]杜联军,吴达明,丁晓毅,等.CT引导淋巴瘤穿刺活检的临床应用[J].介入放射学杂志,2006,(01):25.
 DU Lian-jun,WU Da-ming,DING Xiao-yi,et al.CT-guided biopsy of malignant lymphoma[J].journal interventional radiology,2006,(08):25.
[4]张景俊,首峰,李杰慧,等.125I 粒子植入治疗肝脏边缘恶性肿瘤的临床应用[J].介入放射学杂志,2010,(11):878.
 ZHANG Jing-jun,SHOU Feng,CHEN Yang,et al.Clinical applications of 125I seed brachytherapy in treating malignant tumors located at the marginal zone of liver[J].journal interventional radiology,2010,(08):878.
[5]王忠敏. CT四维电磁导航在肿瘤微创介入治疗中的应用[J].介入放射学杂志,2014,(02):93.
 WANG Zhong? min,CHEN Zhi? jin,LI Lin? sun.. Application of CT 4?蛳 D electromagnetic navigation in performing minimally?蛳 invasive interventional therapy of tumors[J].journal interventional radiology,2014,(08):93.
[6]徐守军,杜端明,刘鹏程,等. 肝肿瘤射频消融术后CT表现及其临床意义[J].介入放射学杂志,2014,(01):69.
 XU Shou? jun,DU Duan? ming,LIU Peng? cheng,et al. CT manifestation and its clinical significance of liver tumors after radiofrequency ablation[J].journal interventional radiology,2014,(08):69.
[7]阮程华,倪才方,陈 珑,等.CT引导下经皮穿刺同轴细针活检术诊断纵隔占位性病变40例[J].介入放射学杂志,2014,(12):1056.
 RUAN Cheng hua,NI Cai fang,CHEN Long,et al.CT guided percutaneous coaxial fine needle biopsy for the diagnosis of mediastinal space occupying lesions: initial experience in 40 cases[J].journal interventional radiology,2014,(08):1056.
[8]王之龙,朱 旭,高顺禹,等.CT减影法评价肝细胞癌TACE后残余肿瘤活性的研究[J].介入放射学杂志,2017,(01):64.
 WANG Zhi- long,ZHU Xu,GAO Shun- yu,et al.Application of CT subtraction technique in evaluating residual hepatocelluar carcinoma activity after transcatheter arterial chemoembolization[J].journal interventional radiology,2017,(08):64.
[9]赵伯翔,顾建平,何 旭,等.下腔静脉滤器长期留置并发症CT随访的单中心研究[J].介入放射学杂志,2016,(11):944.
 ZHAO Bo- xiang,GU Jian- ping,HE Xu,et al.Follow- up checkups with CT scan for the complications induced by long- term retention of indwelling IVC filters: a single- center study[J].journal interventional radiology,2016,(08):944.
[10]杨会军,高 斌.研制专用栅栏提高DSA引导下穿刺定位精度[J].介入放射学杂志,2019,28(04):339.
 YANG Huijun,GAO Bin..The development of specially- designed localizer used for improving DSA- guided puncture localization accuracy[J].journal interventional radiology,2019,28(08):339.

备注/Memo

备注/Memo:
(收稿日期:2023-07-18)
(本文编辑:新宇)
更新日期/Last Update: 2024-08-08